arginine and Deficiency, Factor II

arginine has been researched along with Deficiency, Factor II in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19903 (37.50)18.7374
1990's3 (37.50)18.2507
2000's2 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akhavan, S; Altomare, C; Carotti, A; De Cristofaro, R; Mannucci, PM; Peyvandi, F1
Bezeaud, A; Bournier, O; d'Audigier, C; Guillin, MC; Laurian, Y; Pasmant, E1
Boissel, JP; Elion, J; Jandrot-Perrus, M; Josso, F; Rabiet, MJ1
Henriksen, RA; Mann, KG; Nesheim, ME; Owen, WG1
Girolami, A; James, HL; Kim, DJ; Zheng, DQ1
Augustine, J; Rappaport, EF; Schwartz, E; Shalmon, L; Surrey, S; Tamary, H1
Casey, JT; Dunham, CK; Henriksen, RA; Knupp, CL; Menke, JB; Miller, LD; Usala, SJ1
Brain, MC; Hatton, MW; Pineo, GF; Regoeczi, E1

Other Studies

8 other study(ies) available for arginine and Deficiency, Factor II

ArticleYear
A natural prothrombin mutant reveals an unexpected influence of A-chain structure on the activity of human alpha-thrombin.
    The Journal of biological chemistry, 2004, Mar-26, Volume: 279, Issue:13

    Topics: Animals; Arginine; Blood Platelets; Catalytic Domain; Cell Membrane; Chromatography, High Pressure Liquid; COS Cells; DNA; Fibrinogen; Fibrinopeptide A; Gene Deletion; Humans; Hydrolysis; Hypoprothrombinemias; Ions; Kinetics; Lysine; Models, Molecular; Mutagenesis, Site-Directed; Mutation; Protein Binding; Protein C; Protein Conformation; Protein Structure, Secondary; Prothrombin; Sodium; Sodium Chloride; Thrombin; Time Factors; Transfection

2004
A natural variant with a point mutation resulting in a homozygous Arg to His substitution at position 388 in prothrombin.
    Haematologica, 2008, Volume: 93, Issue:5

    Topics: Arginine; Binding Sites; Child; Chromatography; Female; Genetic Variation; Histidine; Homozygote; Humans; Hypoprothrombinemias; Male; Phenotype; Point Mutation; Prothrombin; Prothrombin Time

2008
Thrombin Metz: characterization of the dysfunctional thrombin derived from a variant of human prothrombin.
    Blood, 1984, Volume: 63, Issue:4

    Topics: Antithrombin III; Arginine; Blood Coagulation; Dansyl Compounds; Enzyme Activation; Fibrinopeptide A; Fibrinopeptide B; Heparin; Humans; Hypoprothrombinemias; Kinetics; Platelet Aggregation; Prothrombin; Thrombin

1984
Identification of a congenital dysthrombin, thrombin Quick.
    The Journal of clinical investigation, 1980, Volume: 66, Issue:5

    Topics: Antithrombin III; Arginine; Calcium; Chromatography, Gel; Dansyl Compounds; Electrophoresis, Polyacrylamide Gel; Factor VIII; Factor X; Factor Xa; Fibrinogen; Humans; Hypoprothrombinemias; Phospholipids; Thrombin

1980
Prothrombin Molise I: documentation of a second incidence of replacement of a critical Arg near the active site.
    Thrombosis research, 1995, Nov-15, Volume: 80, Issue:4

    Topics: Adult; Amino Acid Sequence; Arginine; Autoradiography; Base Sequence; DNA; Exons; Female; Humans; Hypoprothrombinemias; Molecular Sequence Data; Point Mutation; Prothrombin

1995
Molecular analysis of a compound heterozygote for hypoprothrombinemia and dysprothrombinemia (-G 7248/7249 and ARG 340 TRP).
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1997, Volume: 8, Issue:6

    Topics: Adult; Arginine; Codon; Computer Simulation; Female; Frameshift Mutation; Gene Deletion; Heterozygote; Humans; Hypoprothrombinemias; Models, Molecular; Polymerase Chain Reaction; Prothrombin; Sequence Analysis, DNA; Thrombin; Tryptophan

1997
Prothrombin Greenville, Arg517-->Gln, identified in an individual heterozygous for dysprothrombinemia.
    Blood, 1998, Mar-15, Volume: 91, Issue:6

    Topics: Arginine; Cloning, Molecular; DNA Mutational Analysis; Heterozygote; Humans; Hypoprothrombinemias; Male; Middle Aged; Oligopeptides; Partial Thromboplastin Time; Pedigree; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Preoperative Care; Protein Conformation; Prothrombin; Prothrombin Time; Thrombin

1998
The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas.
    The Journal of laboratory and clinical medicine, 1973, Volume: 82, Issue:2

    Topics: Adenocarcinoma, Mucinous; Animals; Arginine; Blood Coagulation; Blood Coagulation Tests; Brain Chemistry; Bronchi; Chemical Precipitation; Disseminated Intravascular Coagulation; Esterases; Factor V Deficiency; Factor VII; Factor VII Deficiency; Factor X; Fibrinogen; Hemophilia B; Humans; Hypoprothrombinemias; Kaolin; Mucins; Mucus; Muramidase; Phospholipids; Prothrombin; Rabbits; Thromboplastin; Time Factors; Venoms

1973